Inflazyme Pharmaceuticals Ltd.
Records under this name other than patents Inflazyme Pharmaceuticals Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Inflazyme Pharmaceuticals Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,601,874 | Indene derivatives as pharmaceutical agents Formerly held Term ended Term ended Mar 26, 2026 · USPTO record | Term ended | Term ended Mar 26, 2026 | USPTO record |
| US 6,458,829 | Substituted &ggr;-phenyl-&Dgr;-lactones and analogs thereof and uses related thereto Formerly held Term ended Term ended May 11, 2021 · USPTO record | Term ended | Term ended May 11, 2021 | USPTO record |
| US 6,770,658 | Substituted &ggr;-phenyl-&Dgr;-lactams and uses related thereto Formerly held Term ended Term ended Sep 29, 2019 · USPTO record | Term ended | Term ended Sep 29, 2019 | USPTO record |
| US 6,635,629 | 3-nitrogen-6,7-dioxygen steroids and uses related thereto Formerly held Lapsed on the fee record Ended Oct 21, 2015 · USPTO record | Lapsed on the fee record | Ended Oct 21, 2015 | USPTO record |
| US 6,555,572 | Benzylated PDE4 inhibitors Formerly held Lapsed on the fee record Ended Apr 29, 2015 · USPTO record | Lapsed on the fee record | Ended Apr 29, 2015 | USPTO record |
| US 7,112,580 | 3-nitrogen-6, 7-dioxygen steroids and uses related thereto Formerly held Lapsed on the fee record Ended Sep 26, 2014 · USPTO record | Lapsed on the fee record | Ended Sep 26, 2014 | USPTO record |
| US 6,982,329 | Process improvements in steroid chemistry Formerly held Lapsed on the fee record Ended Jan 3, 2014 · USPTO record | Lapsed on the fee record | Ended Jan 3, 2014 | USPTO record |
| US 7,459,479 | Benzylated PDE4 inhibitors Formerly held Lapsed on the fee record Ended Dec 2, 2012 · USPTO record | Lapsed on the fee record | Ended Dec 2, 2012 | USPTO record |
| US 7,446,129 | Benzylated PDE4 inhibitors Formerly held Lapsed on the fee record Ended Nov 4, 2012 · USPTO record | Lapsed on the fee record | Ended Nov 4, 2012 | USPTO record |
| US 6,046,185 | 6,7-oxygenated steroids and uses related thereto Lapsed on the fee record Ended Apr 4, 2012 · USPTO record | Lapsed on the fee record | Ended Apr 4, 2012 | USPTO record |